
Femtobiomed Inc. — Investor Relations & Filings
Femtobiomed Inc. is a cell engineering company that develops technologies for the cell and gene therapy industry. The company's core offering is the CellShot® platform, a proprietary, non-viral intracellular delivery system. This platform utilizes a patented technology known as 'Partitioned Flow Transfection,' which functions as a three-dimensional nanoinjection system for the direct, cargo-free delivery of biomolecules into individual cells. The technology is designed to support the discovery and development of advanced therapeutics, including anti-cancer treatments, for the healthcare and research sectors. Femtobiomed aims to pioneer non-viral cell engineering to accelerate the creation of novel cell therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 기타시장안내 (상장폐지 관련) | 2026-04-13 | Korean | |
| 주권매매거래정지기간변경 (상장폐지사유 발생) | 2026-04-13 | Korean | |
| 정기주주총회결과 | 2026-03-31 | Korean | |
| 기타시장안내 (상장폐지 관련) | 2026-03-30 | Korean | |
| 사업보고서 (2025.12) | 2026-03-30 | Korean | |
| 주권매매거래정지 (상장폐지사유 발생) | 2026-03-30 | Korean |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 34380647 | 기타시장안내 (상장폐지 관련) | 2026-04-13 | Korean | ||
| 34380646 | 주권매매거래정지기간변경 (상장폐지사유 발생) | 2026-04-13 | Korean | ||
| 33119826 | 정기주주총회결과 | 2026-03-31 | Korean | ||
| 33085997 | 기타시장안내 (상장폐지 관련) | 2026-03-30 | Korean | ||
| 33085992 | 사업보고서 (2025.12) | 2026-03-30 | Korean | ||
| 33085587 | 주권매매거래정지 (상장폐지사유 발생) | 2026-03-30 | Korean | ||
| 33085585 | 감사보고서제출 | 2026-03-30 | Korean | ||
| 33054006 | 본점소재지변경 | 2026-03-27 | Korean | ||
| 33012274 | 사업보고서제출기한연장신고서 (2025.12) | 2026-03-23 | Korean | ||
| 32982207 | 기타주요경영사항(자율공시) (기타주요경영사항(자율공시)(감사보고서 제출 지연)) | 2026-03-19 | Korean | ||
| 32932519 | 주주총회소집공고 | 2026-03-12 | Korean | ||
| 32838375 | 주주총회소집결의 | 2026-02-26 | Korean | ||
|
2025
3 filings
| |||||
| 33030887 | 주식등의대량보유상황보고서(일반) | 2025-11-06 | Korean | ||
| 33030883 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2025-11-06 | Korean | ||
| 7891749 | 주식등의대량보유상황보고서(일반) | 2025-06-19 | Korean | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AIM ImmunoTech Inc.
Immuno-pharma company developing therapeutics for oncology,…
|
AIM | US | Professional, scientific and te… |
|
Ainos, Inc.
Develops AI-driven diagnostics, immune therapeutics, and te…
|
AIMD | US | Professional, scientific and te… |
|
Akela Pharma Inc.
Integrated drug developer focused on pain and inhalation, p…
|
— | CA | Professional, scientific and te… |
|
Akero Therapeutics, Inc.
Clinical-stage company developing treatments for serious me…
|
AKRO | US | Professional, scientific and te… |
|
Aladdin Healthcare Technologies SE
Develops AI-powered tools for drug discovery and diagnostic…
|
NMI | DE | Professional, scientific and te… |
|
Alaunos Therapeutics, Inc.
Clinical-stage immuno-oncology company developing TCR-T cel…
|
TCRT | US | Professional, scientific and te… |
|
ALGORAE PHARMACEUTICALS LIMITED
Biopharmaceutical firm using AI to develop neurodegenerativ…
|
1AI | AU | Professional, scientific and te… |
|
Aligos Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
ALGS | US | Professional, scientific and te… |
|
Allelix Biopharmaceuticals Inc.
Biopharmaceutical R&D focused on protein-based drugs and ne…
|
ALX | CA | Professional, scientific and te… |
|
Alpha Tau Medical Ltd.
Clinical-stage oncology firm developing alpha radiation the…
|
DRTS | US | Professional, scientific and te… |
Femtobiomed Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16340/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16340 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16340 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16340 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16340}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Femtobiomed Inc. (id: 16340)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.